• LevinPro HC Stat of the Week, December 5, 2025

    eHealth Activity Hits 3-Year High (Already) Source: LevinPro HC, December 2025 With still a month left in 2025, eHealth M&A activity has hit a 3-year high, with 280 deal announcements, a 13% increase over last year’s volume. Although AI has been a hot topic in healthcare (and just about everywhere), our LevinPro HC data shows that... Read More »
  • INVO Fertility Acquires Family Beginnings 

    INVO Fertility, part of INVO Bioscience, Inc., reported on November 28 that it was expanding its presence with the acquisition of Family Beginnings.  Family Beginnings is a fertility clinic based in Indianapolis, Indiana. According to its website, the practice is run by Dr. James G. Donahue.  Founded in 2009, INVO Fertility healthcare... Read More »
  • Hims & Hers to Acquire YourBio Health

    Leading health and wellness platform Hims & Hers Health, Inc. announced that it has entered into a definitive agreement to acquire YourBio Health, Inc., a Flagship Pioneering portfolio company. YourBio Health is a Boston-based pioneer in capillary whole blood sampling technology. The company invented ‘Touch-Activated Phlebotomy’ for virtually... Read More »
  • BriteLife Recovery Buys New Jersey-Based Summit Behavioral Health

    BriteLife Recovery will be acquiring Summit Behavioral Health, according to a December 2 announcement. The acquisition marks BriteLife Recovery’s first expansion into outpatient programming. Summit Behavioral Health is a community-based intensive outpatient program (IOP) in Princeton Junction, New Jersey. BriteLife Recovery is a provider of... Read More »
  • INVO Fertility Acquires Family Beginnings 

    INVO Fertility, part of INVO Bioscience, Inc., reported on November 28 that it was expanding its presence with the acquisition of Family Beginnings.  Family Beginnings is a fertility clinic based in Indianapolis, Indiana. According to its website, the practice is run by Dr. James G. Donahue.  Founded in 2009, INVO Fertility healthcare... Read More »
CQ Medical Buys Bionix Business Unit to Expand Radiation Therapy Portfolio

CQ Medical Buys Bionix Business Unit to Expand Radiation Therapy Portfolio

CQ Medical announced that it will be acquiring Bionix’s radiation therapy business unit, marking an expansion of its patient positioning and marking product portfolio. Bionix has been focused on developing medical devices across multiple patient care segments for more than 40 years. The company is based in Maumee, Ohio. CQ Medical was formed in 2022 through the combination of CIVCO Radiotherapy and Qfix, bringing together decades of expertise in advanced radiation therapy positioning and immobilization solutions. The CQ Medical portfolio covers a range of clinical applications, including devices for precision stereotactic treatment and proton therapy, implantable fiducial markers for... Read More »
Blackstone and TPG Acquire Hologic in $18.3 Billion Deal 

Blackstone and TPG Acquire Hologic in $18.3 Billion Deal 

On October 20, TPG and Blackstone announced that they entered into a definitive agreement to acquire Hologic, Inc. The purchase represents an enterprise value of up to $18.3 billion.  Founded in 1985, Hologic develops, manufactures and sells premium diagnostic products, medical imaging systems and surgical products, primarily for women’s health. Hologic reported an annual revenue of more than $4 billion for its 2024 fiscal year, which ended on September 28, 2024.  TPG is a global alternative asset management firm. It was founded in San Francisco in 1992 and has $246 billion of assets under management.  Blackstone is the world’s largest alternative asset manager. The... Read More »
Avanos Medical Bolsters Device Portfolio With Nexus Medical

Avanos Medical Bolsters Device Portfolio With Nexus Medical

On September 15, Avanos Medical, Inc. announced the acquisition of Nexus Medical, LLC for an undisclosed price. Nexus Medical is a Lenexa, Kansas-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. Nexus is renowned for its TKO anti-reflux needleless connector technology, which enhances the safety and consistency of nutrition and medication delivery, particularly in high-acuity settings like neonatal and pediatric intensive care units. Avanos Medical is a medical technology company focused on delivering clinically superior breakthrough medical device... Read More »
Keensight Capital Acquires Majority Stake in Isto Biologics

Keensight Capital Acquires Majority Stake in Isto Biologics

French private equity firm Keensight Capital announced it has agreed to acquire a majority stake in Isto Biologics from Thompson Street Capital Partners. Founded in 2016, Isto Biologics is a regenerative MedTech company developing and manufacturing orthobiologic products to help patients heal faster. Isto’s product offering covers six functional areas of unique bone graft solutions, and includes a range of allografts, which are notably used for bone repair in the spine. Isto sells its products to more than 400 hospitals and clinics, which are used in 15,000 surgical procedures per month, primarily in the United States. Keensight Capital is a European growth buyout firm. With more than 25... Read More »
Keensight Capital Acquires Majority Stake in Isto Biologics

Alcon to Acquire STAAR Surgical Company

According to an August 5 announcement, Alcon has entered into a definitive merger agreement to acquire STAAR Surgical Company. The transaction represents a total equity value of approximately $1.5 billion. STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. According to its most recent annual report, STAAR generated $313.9 million in revenue during the fiscal year 2024 and had an EBITDA loss of $8 million. Alcon, a division of Novartis, researches and develops products for eye conditions such as cataracts, glaucoma, retinal diseases and refractive... Read More »
Avanos Medical Bolsters Device Portfolio With Nexus Medical

ArchiMed Acquires ZimVie for $730 Million 

On July 21, ArchiMed announced that it purchased ZimVie for $730 million. ZimVie stockholders will receive $19 in cash for each share of ZimVie common stock outstanding at the closing of the transaction.   ZimVie is a global life sciences leader in the dental market that develops, manufactures and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. Zimvie spun out of Zimmer Biomet in 2022 and has since broken off into smaller pieces.   ArchiMed is an independent private equity investment firm focused exclusively on the healthcare industry. It has directly managed and invested in more than... Read More »